10/17/2024 3:54 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 15-12G | |
10/04/2024 3:21 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024 3:24 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024 3:27 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024 3:30 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024 3:33 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024 3:36 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024 3:18 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024 3:16 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form POSASR | |
08/27/2024 9:14 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
Get the Latest News and Ratings for MPSYF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.
|
08/13/2024 3:31 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/07/2024 3:51 PM | MorphoSys AG (Subject) MorphoSys (Subject)
| Form SC 14D9/A | |
08/07/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/05/2024 7:14 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/01/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/31/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/30/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/29/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:05 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 25 Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/18/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/18/2024 10:25 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 3:20 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/05/2024 5:48 AM | MorphoSys AG (Subject) MorphoSys (Subject)
| Form SC 14D9 | |
07/05/2024 5:02 AM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T | |
07/02/2024 9:18 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/21/2024 9:07 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:41 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:33 PM | MorphoSys AG (Subject) MorphoSys (Subject)
| Form SC14D9C | |
06/20/2024 2:38 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-C | |
06/17/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 11:06 AM | GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by) MorphoSys AG (Subject) MorphoSys (Subject)
| Form SC 13G/A | |
06/10/2024 10:01 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024 3:36 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024 9:22 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
DOGE To DO List (Ad) Elon's found so much waste he's now claiming "the magnitude of the fraud in federal entitlements" is greater than "the combined sum of every private scam you've ever heard by FAR"...
And while this is disturbing and even infuriating to see our tax money literally wasted... there IS a solution.
I believe it's Elon's ultimate end game. I'll walk you through it here. |
06/04/2024 9:17 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024 9:17 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024 9:17 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 9:16 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024 9:13 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 1:19 PM | MorphoSys AG (Subject) MorphoSys (Subject)
| Form SC 14D9/A | |
05/23/2024 9:11 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 8:04 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024 9:07 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024 9:15 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024 3:43 PM | MorphoSys AG (Subject) MorphoSys (Subject)
| Form SC 14D9/A | |
05/16/2024 3:31 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/16/2024 9:11 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024 9:09 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 9:27 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024 9:19 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2024 9:31 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024 9:08 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 3:45 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/07/2024 9:24 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/06/2024 9:07 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2024 9:29 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024 3:31 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/02/2024 9:43 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 9:07 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 7:57 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 3:15 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 9:17 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/26/2024 9:11 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/25/2024 9:38 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 10:03 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2024 9:14 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 9:32 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024 9:17 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024 3:31 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/18/2024 1:33 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC 13D | |
04/18/2024 9:13 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2024 3:49 PM | MorphoSys AG (Subject) MorphoSys (Subject)
| Form SC 14D9/A | |
04/17/2024 3:30 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024 4:07 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024 9:12 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024 2:44 PM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/12/2024 9:54 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 10:57 AM | MorphoSys AG (Subject) MorphoSys (Subject)
| Form SC 14D9 | |
04/11/2024 5:01 AM | MorphoSys AG (Subject) MorphoSys (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T | |
04/09/2024 9:07 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 9:19 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 9:15 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
DOGE To DO List (Ad) Elon's found so much waste he's now claiming "the magnitude of the fraud in federal entitlements" is greater than "the combined sum of every private scam you've ever heard by FAR"...
And while this is disturbing and even infuriating to see our tax money literally wasted... there IS a solution.
I believe it's Elon's ultimate end game. I'll walk you through it here. |
04/02/2024 9:08 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024 12:16 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024 10:15 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2024 10:37 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024 10:17 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024 5:47 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2024 10:27 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 3:12 PM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 10:13 AM | MorphoSys AG (Filer) MorphoSys (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |